Contraline released promising new trial data showing that its male contraceptive gel has demonstrated safety and efficacy in the first two trial participants to reach the two-year mark. The company is aiming to earn the product’s FDA approval by the end of 2028, according to CEO Kevin Eisenfrats.
The post Trial Data Shows ‘IUD for Men’ Is Effective for 2 Years appeared first on MedCity News.
